CPDC (Centre for Probe Development and Commercialization)
Biotechnology ResearchOntario, Canada11-50 Employees
CPDC is a not-for-profit biotechnology organization based in Hamilton, Ontario, founded in 2008 to advance radiopharmaceuticals for nuclear medicine and to improve Canadian patient outcomes through research commercialization and clinical development. The organization identifies and develops critical radiopharmaceuticals and moves them toward clinical use through collaborations with industry, academia and government, aiming to expand access for Canadian physicians and patients. Over its history, CPDC has formed four Canadian commercial entities that have advanced the availability of radiopharmaceuticals to the Canadian medical community. The company operates in the biotechnology research landscape with a focus on translating research into clinical practice through partnerships spanning industry, academia and government. In 2020, CPDC appointed Justyna Kelly as Chief Executive Officer.